Effects of the October 2023 war on diabetes treatment and medication adherence in Gaza

Abstract

Background: Diabetes management requires lifelong medical and medication supervision. The war in Gaza has worsened essential care for diabetes patients, disrupting access to treatment and medications and causing non-adherence. Aim: To evaluate the effects of the October 2023 war on diabetes treatment and medication compliance in Gaza. Methods: Between February and May 2024, this cross-sectional study collected data from 278 diabetes patients residing in Rafah, Gaza Strip. It analysed the impact of the war on access to care and medications and medication adherence. Results: Access to health care facility had decreased from 90% before the October 2023 war to 22% at the time of the study, and medication adherence had decreased from 85% to 45%. Financial constraints severely impacted medication affordability (55% significantly, 37% moderately, 7% lightly, and only 1% not at all) and medication adherence (65% due to mild constraint, 40% due to moderate constraint and 15% due to high constraint). Conclusion: Findings from this study indicate the need for accelerated assistance to rehabilitate health infrastructure and services in Gaza to guarantee continuous care for diabetic patients and patients suffering from other chronic diseases.